{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T09:43:21Z","timestamp":1781430201579,"version":"3.54.1"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800288"],"award-info":[{"award-number":["81800288"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81741026"],"award-info":[{"award-number":["81741026"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571515"],"award-info":[{"award-number":["81571515"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science\u2010technology Support Plan Projects in Sichuan province","award":["2017SZ0117"],"award-info":[{"award-number":["2017SZ0117"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0214873","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T17:50:00Z","timestamp":1557856200000},"page":"e0214873","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Placental P-glycoprotein inhibition enhances susceptibility to Di-(2-ethylhexyl)-phthalate induced cardiac malformations in mice: A possibly promising target for congenital heart defects prevention"],"prefix":"10.1371","volume":"14","author":[{"given":"Changqing","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3096-4287","authenticated-orcid":true,"given":"Yifei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajian","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5165-8273","authenticated-orcid":true,"given":"Chuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,5,14]]},"reference":[{"issue":"2","key":"ref1","first-page":"223","article-title":"The risk of adverse reproductive and developmental disorders due to occupational pesticide exposure: an overview of current epidemiological evidence","volume":"17","author":"W Hanke","year":"2004","journal-title":"International journal of occupational medicine and environmental health"},{"issue":"8","key":"ref2","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/occmed\/kql115","article-title":"Maternal occupational exposure and risk of specific birth defects","volume":"56","author":"AM Thulstrup","year":"2006","journal-title":"Occup Med (Lond)"},{"issue":"9","key":"ref3","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/oemed-2011-100536","article-title":"Association between maternal occupational exposure to organic solvents and congenital heart defects, National Birth Defects Prevention Study, 1997\u20132002","volume":"69","author":"SM Gilboa","year":"2012","journal-title":"Occup Environ Med"},{"issue":"11","key":"ref4","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/bdra.23071","article-title":"Maternal occupational exposure to polycyclic aromatic hydrocarbons and congenital heart defects among offspring in the national birth defects prevention study","volume":"94","author":"PJ Lupo","year":"2012","journal-title":"Birth defects research Part A, Clinical and molecular teratology"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s00246-015-1116-6","article-title":"Parental occupational exposures to endocrine disruptors and the risk of simple isolated congenital heart defects","volume":"36","author":"C Wang","year":"2015","journal-title":"Pediatric cardiology"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/jat.3591","article-title":"The effect of maternal exposure to di-(2-ethylhexyl)-phthalate on fetal cardiac development in mice","volume":"38","author":"C Tang","year":"2018","journal-title":"Journal of applied toxicology: JAT"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.placenta.2012.01.008","article-title":"Placental drug transporters and their role in fetal protection","volume":"33","author":"M Iqbal","year":"2012","journal-title":"Placenta"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"674","DOI":"10.2174\/138920111795164057","article-title":"ATP-binding cassette efflux transporters in human placenta","volume":"12","author":"ZMQ Ni","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1124\/dmd.110.033571","article-title":"The role of the placenta in fetal exposure to xenobiotics: importance of membrane transporters and human models for transfer studies","volume":"38","author":"C Prouillac","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1476-5381.2009.00336.x","article-title":"Drug transporters in the human blood-placental barrier","volume":"158","author":"K Vahakangas","year":"2009","journal-title":"Br J Pharmacol"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1517\/17425250903304049","article-title":"Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues","volume":"5","author":"PIE Myllynen","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.placenta.2004.09.006","article-title":"Human placenta: a human organ for developmental toxicology research and biomonitoring","volume":"26","author":"P Myllynen","year":"2005","journal-title":"Placenta"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.reprotox.2006.01.007","article-title":"P-glycoprotein in the placenta: expression, localization, regulation and function","volume":"22","author":"M Ceckova-Novotna","year":"2006","journal-title":"Reproductive toxicology (Elmsford, NY)"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1517\/17425255.2010.514264","article-title":"ABCB1 and ABCG2 expression in the placenta and fetus: an interspecies comparison","volume":"6","author":"P Myllynen","year":"2010","journal-title":"Expert opinion on drug metabolism & toxicology"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/mrd.20734","article-title":"The role of multiple drug resistance proteins in fetal and\/or placental protection against teratogen-induced orofacial clefting","volume":"74","author":"LA Rawles","year":"2007","journal-title":"Molecular reproduction and development"},{"issue":"7","key":"ref16","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2217\/pgs.14.62","article-title":"Pharmacogenetics of drug-induced birth defects: the role of polymorphisms of placental transporter proteins","volume":"15","author":"AN Daud","year":"2014","journal-title":"Pharmacogenomics"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0890-6238(98)00027-6","article-title":"PLACENTAL P-GLYCOPROTEIN DEFICIENCY ENHANCES SUSCEPTIBILITY TO CHEMICALLY INDUCED BIRTH DEFECTS IN MICE","volume":"12","author":"WL Lankas GR","year":"1998","journal-title":"Reproductive Toxicology"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1172\/JCI7963","article-title":"Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure","volume":"104","author":"JW Smit","year":"1999","journal-title":"The Journal of clinical investigation"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"e68807","DOI":"10.1371\/journal.pone.0068807","article-title":"Increased risk for congenital heart defects in children carrying the ABCB1 Gene C3435T polymorphism and maternal periconceptional toxicants exposure","volume":"8","author":"C Wang","year":"2013","journal-title":"PloS one"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.etap.2006.11.001","article-title":"Di(2-ethylhexyl)phthalate leached from medical PVC devices serves as a substrate and inhibitor for the P-glycoprotein","volume":"23","author":"JH Kim","year":"2007","journal-title":"Environmental toxicology and pharmacology"},{"issue":"25","key":"ref21","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/j.jacc.2013.02.058","article-title":"The P-glycoprotein transport system and cardiovascular drugs","volume":"61","author":"JD Wessler","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"4","key":"ref22","first-page":"e17741","article-title":"Verapamil and Rifampin Effect on P-Glycoprotein Expression in Hepatocellular Carcinoma","volume":"9","author":"AGS Jalali","year":"2014","journal-title":"Jundishapur journal of natural pharmaceutical products"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1124\/dmd.113.056176","article-title":"Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?","volume":"42","author":"R Callaghan","year":"2014","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s40256-013-0029-0","article-title":"Drug-drug interaction studies of cardiovascular drugs involving P-glycoprotein, an efflux transporter, on the pharmacokinetics of edoxaban, an oral factor Xa inhibitor","volume":"13","author":"J Mendell","year":"2013","journal-title":"Am J Cardiovasc Drugs"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hup.1008","article-title":"Verapamil in treatment resistant depression: a role for the P-glycoprotein transporter?","volume":"24","author":"G Clarke","year":"2009","journal-title":"Human psychopharmacology"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4062\/biomolther.2013.105","article-title":"Identification of p-glycoprotein and transport mechanism of Paclitaxel in syncytiotrophoblast cells","volume":"22","author":"NY Lee","year":"2014","journal-title":"Biomolecules & therapeutics"},{"issue":"9","key":"ref27","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1002\/jps.23551","article-title":"Evaluation of rat in vivo fetal-to-maternal transfer clearances of various xenobiotics by umbilical perfusion","volume":"102","author":"T Nishimura","year":"2013","journal-title":"Journal of pharmaceutical sciences"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.rvsc.2010.05.020","article-title":"Teratogenic and cytogenetic effects of ivermectin and its interaction with P-glycoprotein inhibitor","volume":"90","author":"IM el-Ashmawy","year":"2011","journal-title":"Research in veterinary science"},{"issue":"2\u20133","key":"ref29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.placenta.2004.05.013","article-title":"P-glycoprotein expression of the human placenta during pregnancy","volume":"26","author":"S Gil","year":"2005","journal-title":"Placenta"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.placenta.2010.02.010","article-title":"Placental P-glycoprotein and breast cancer resistance protein: influence of polymorphisms on fetal drug exposure and physiology","volume":"31","author":"JR Hutson","year":"2010","journal-title":"Placenta"},{"issue":"10","key":"ref31","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1002\/ajmg.a.33036","article-title":"Maternal medication use, carriership of the ABCB1 3435C > T polymorphism and the risk of a child with cleft lip with or without cleft palate","volume":"149A","author":"BJ Bliek","year":"2009","journal-title":"American journal of medical genetics Part A"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/ejhg.2013.25","article-title":"Fetal polymorphisms at the ABCB1-transporter gene locus are associated with susceptibility to non-syndromic oral cleft malformations","volume":"21","author":"A Omoumi","year":"2013","journal-title":"European journal of human genetics: EJHG"},{"issue":"7","key":"ref33","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s40264-015-0299-3","article-title":"P-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study","volume":"38","author":"AN Daud","year":"2015","journal-title":"Drug Saf"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0214873","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T01:11:13Z","timestamp":1721265073000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0214873"}},"subtitle":[],"editor":[{"given":"Cheryl S.","family":"Rosenfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0214873","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,14]]}}}